blue-and-white capsules spilling from a prescription medicine bottle across the corner of a prescription

Hoffman Warnick Helps Vanda Protect Drug Treatment Patent

Hoffman Warnick Helps Vanda Protect Drug Treatment Patent We are proud to have assisted our client, Vanda Pharmaceuticals, in an important patent case that allows the company to retain market exclusivity for one of their important drug products until 2027. On January 13, 2020, the US Supreme Court denied Hikma Pharmaceuticals’ petition for a writ…

ERNEST G. CUSICK AND FRANKLIN S. ABRAMS JOIN FIRM

ERNEST G. CUSICK AND FRANKLIN S. ABRAMS JOIN FIRM Hoffman Warnick is proud to announce the appointment of Ernest Cusick as Counsel and Franklin Abrams as Special Counsel. Ernest G. Cusick Ernest Cusick’s practice focuses on patent strategy and procurement, as well as technology development. Mr. Cusick has worked with a wide array of clients,…

Graph showing the growing number of Artificial Intelligence patents that have reached Publication and Issuance

Artificial Intelligence Patents Growing Exponentially

ARTIFICIAL INTELLIGENCE PATENTS GROWING EXPONENTIALLY The attached chart depicts a graphical trend of the growing number of issued patents and published patent applications that involve Artificial Intelligence (AI). AI patents fall into two general categories. Those that use AI for a specific application such as autonomous driving cars, image recognition, data analysis, etc., and those that…

Seal of the Supreme Court of the US

Supreme Court Hears Apple v. Samsung

Supreme Court Hears Apple v. Samsung Apple squares off with Samsung today before the United States Supreme Court, addressing a long-standing dispute relating to the design of the early version iPhone, first brought to light in a 2012 trial. This is the first design patent dispute heard by the Court in over a century. At…

Seal of US Patent and Trademark Office

US Patent & Trademark Office Launches Pilot Program

US Patent & Trademark Office Launches Pilot Program for Early Review of Cancer Immunotherapy Patent Applications The U.S. Patent and Trademark Office (USPTO) announced on June 30, 2016, that it is implementing a 12-month pilot program to provide for earlier review of patent applications relating to cancer immunotherapy.  According to the Federal Register notice (link…